Notice of AGM

RNS Number : 1430D
Seraphim Space Investment Trust PLC
19 October 2022
 

SERAPHIM SPACE INVESTMENT TRUST PLC

 

("the Company" or "SSIT")

 

 

The Company announces that its Annual General Meeting ("AGM") will be held at 1 Fleet Place, London, EC4M 7WS (GPS postcode: EC4M 7RA) at 11.00 a.m. on 17 November 2022.

The Notice of AGM has been dispatched to shareholders. An electronic copy of the Notice of AGM is also available on the Company's website https://investors.seraphim.vc/ .

 

A copy of the Notice and Form of Proxy can be inspected at the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

- Ends -

 

Media Enquiries

Seraphim Space Manager LLP (via SEC Newgate)
Mark Boggett, CEO / James Bruegger, CIO / Rob Desborough  

 

SEC Newgate (Communications advisers)                              seraphim@secnewgate.co.uk  
Emma Kane / Clotilde Gros / George Esmond  +44 (0) 20 3757 6767
 

Deutsche Bank 
Mark Hankinson / Gavin Deane / Neil Coleman                                        +44 (0) 20 7545 8000
 

J.P. Morgan Cazenove
William Simmonds / Jérémie Birnbaum / Rupert Budge  +44 (0) 20 7742 4000
 

Ocorian Administration (UK) Limited       seraphimteam@ocorian.com  

Lorna Zimny    +44 28 9078 5880

 

Notes to Editors

 

About Seraphim Space Investment Trust

 

Seraphim Space Investment Trust plc is the world's first listed fund focused on SpaceTech. The Company seeks exposure predominantly to early and growth stage privately financed SpaceTech businesses that have the potential to dominate globally and that are category leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.

 

The Company listed on the London Stock Exchange on 14 July 2021, following an oversubscribed IPO raising £150.0m of fresh capital.  As at 30 June 2022, the Company had net assets of £239.3m and exposure to more than 25 Space Tech companies.

 

Seraphim Space Investment Trust plc is managed by Seraphim Space Manager LLP.

 

Further information is available at:  https://investors.seraphim.vc/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOABKOBDNBDDOKD
UK 100